clinical aspects of neoplasia hs

Upload: jshy-shy

Post on 03-Jun-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    1/19

    DR SHWE SIN

    FMHS

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    2/19

    It is the effects of neoplasmson the patients

    Tumor-Host interactions area two way street

    Any tumor even benign one

    may cause morbidityandmortality

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    3/19

    Because of:

    1. Location and impingementon adjacent

    structures (site and size)

    2. Functional activity such as hormone

    synthesis or the development ofparaneoplastic syndromes

    3. Bleedingand infections

    4. Symptoms results from ruptureor

    infarction5. Cachexiaor wasting

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    4/19

    I. Local effects:

    1) Location- impingement and obstruction

    2) Bleeding, ulceration, secondary

    infection3) Infarction (due to torsion)

    4) Functional activity (hormone

    production)

    II. Cachexia

    III. Paraneoplastic syndromes

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    5/19

    Locationis important: Impingement and

    obstruction on adjacent structures

    e.g - A small (1 cm) pituitary adenoma can

    compress and destroy the surrounding normalgland

    - A 0.5 cm leiomyoma in the wall of

    renal artery may lead to renal ischemia

    - A small carcinoma within common bileduct may induce fatal biliary tract

    obstruction

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    6/19

    A tumor may ulcerateleading to

    bleeding or secondary infection

    Benign or malignant neoplasmsthat protrude into gut lumen

    may cause intussusception,

    obstructionor infarction

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    7/19

    Hormone production is also important:- Adenomas and carcinomas arising in the b-

    cells of the islets of the pancreas can

    produce fatal hyperinsulinism

    - Some adenomas and carcinomas of adrenalcortex elaborate corticosteroids that affect

    the patients

    - Hormonal activity is more likely in benign

    tumor than carcinoma

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    8/19

    Cancer patients suffer

    progressive loss of body fat and

    lean body massAccompanied by profound

    weakness, anorexia, wasting

    and anaemiacachexia

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    9/19

    Due to action of cytokinesproduced bytumor and the host (e.g TNF)suppresses appetite and inhibit releaseof free fatty acids

    Calorie expenditure remains high and

    basal metabolic rate is increasedOther: protein-mobilizing factor called

    proteolysis-inducing factor play somerole

    Also attributed by grief and anxietyThere is no satisfactory treatment

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    10/19

    Symptom complex

    That cannot be readily explained by local ordistant spread

    By elaboration of hormonesindigenous to the

    tissue of origin paraneoplastic syndromes Appear 10- 15 % of patients

    May be - earliest manifestation

    - represent significant

    clinical problems- lethal

    - mimic metastatic

    disease

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    11/19

    The most common syndromes are:

    - hypercalcemia(e.g breast cancers)- Cushing syndrome (e.glung cancers)

    - nonbacterial thrombotic endocarditis (e.ghaematologic malignancies)

    Hypercalcemiadue to synthesis of

    parathyroid hormone-related protein (PTHrP)by tumor cells

    Cushing syndrome- due to ectopicproduction of ACTHor ACH-like polypeptides

    by cancer cellsNonbacterial thrombotic endocarditis -

    Substances that can cause hypercoagulability

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    12/19

    GRADING:NecessaryHistologic estimate of malignancy of a

    tumorFor making accurate prognosisand fortreatmentprotocols

    Criteria depends on- degree ofdifferentiation, nuclear pleomorphismand hyperchromasia & number of mitoses

    Classified as grade I, II, III or IVOr Well, Moderate and Poorly

    differentiated

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    13/19

    STAGING: It is clinical estimate of extent of tumor spread

    Staging is determined by surgical explorationor imaging

    Two methods of staging are currently used: theTMN system and the AJCC system

    Based on :1. Tumorsize (T) T0 to T4

    2. local and regional lymph node spread (N) N0to N3

    3. distant metastasis (M) M0 to M1/M2

    Staging has greater clinical value than grading

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    14/19

    Biopsy and histology

    Cytology(Fine needle aspiration

    cytology FNAC)

    Immunohistohistochemistry(IHC)

    and Immunocytochemistry

    Flow cytometry

    Tumor Markers (e.g CEA)

    Molecular diagnosis (e.g PCR)

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    15/19

    Biopsy is the tissue specimen made available for

    histological diagnosis

    Biopsy & histology is the most important method

    of tumor diagnosis

    Provides definitive diagnosis (Gold standard)

    The specimen must be adequate, representative

    and properly preserved

    Several sampling are available:- excisional, incisional, punch, wedge, cone and

    fine-needle aspiration biopsy

    Routine stain- Haematoxylin and Eosin (H&E)

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    16/19

    Fine-needle aspiration of tumors (FNAC &FNAB)- is widely used

    Next best to histology

    Involves aspiration of cells from mass,followed by cytologic examination of thesmear (? Dysplasia or anaplasia)

    Can apply in readily palpable lesionsaffecting breast, thyroid, lymph nodes and

    salivary glandsCan also apply in deeper structures (liver,

    pancreas and pelvic lymph nodes) by usingModern imaging techniques (USG, CT scan)

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    17/19

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    18/19

    Robbins Basic Pathology, 8thEdition

  • 8/11/2019 Clinical Aspects of Neoplasia Hs

    19/19